Login
Navigate Fool.com
Will SCMP beat
the market?
Community Rating: 4 Stars: Favorite

6.25 -0.02 (-0.32%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.27
Previous Close $6.27
Daily Range $6.16 - $6.33
52-Week Range $5.40 - $11.00
Market Cap $276.6M
P/E Ratio 25.08
Dividend (Yield) $0.00 (0.0%)
Volume 65,877
Average Daily Volume 113,454
Current FY EPS $0.11

How do you think SCMP
will perform against the market?

Top SCMP Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted July 1, 2012

Sucampo is retesting price levels seen shortly after the company announced positive results from the phase III trial of lubiprostone in opiate bowel dysfunction. The share price rose as high as 8.5 bu … More

0 Replies Reply Report this Post
 

drugncover (< 20)
Submitted October 5, 2007

Talk about inside dealing... reading the prospectus of this company is like wading through a swamp. They hold certain rights to all their compounds in a separate company, that the CEO of this company … More

2 Replies Reply Report this Post

News & Commentary Rss Feed

Why Sucampo Pharmaceuticals, Inc. Shares Temporarily Dropped

Sucampo shares hit the deck, at least briefly, after reporting its first-quarter results. Find out if this dip is a buying opportunity for investors or a reason to keep your distance.

Why Sucampo Pharmaceuticals, Inc. Shares Jumped

Sucampo shares are off to the races after topping Wall Street's profit expectations in the fourth-quarter. Is this earnings beat meaningful or just white noise?

Why Sucampo Pharmaceuticals, Inc. Shares Popped

Sucampo's 8-K filing with the SEC delivers a nice surprise to shareholders.

Synergy Pharma Seeks to Treat Gastral Disorders And Diseases

Sector Update: Healthcare Shares Flat; Pluristem Therapeutics up 4% on Partnership with CHA Bio & Di

Sector Update: Healthcare Shares Flat; Pluristem Therapeutics up 4% on Partnership with CHA Bio & Diostech

Sector Update: Healthcare

Weekly CEO Sells Highlight: Sucampo Pharmaceuticals Inc, Family Dollar Stores Inc, Nike Inc, ...

Sector Update: Healthcare Shares Flat; Agenus up 10% on Malaria Vaccine Data

Sector Update: Healthcare

A One of a Kind Flagship Drug for Your Irritable Bowel

See More SCMP News...

Sector

Healthcare

Industry

Drugs

SUCAMPO PHARMACEUTICALS, INC. (SCMP) Description

An emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. Website: http://www.sucampo.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks